Islet Sciences, Inc: 10-Q filed 2013-12-10

Name: Islet Sciences, Inc: 10-Q filed 2013-12-10
Creator: Islet Sciences, Inc
License: https://creativecommons.org/licenses/by/4.0/

What Islet Sciences, Inc reported in its quarterly report filed 2013-12-10 (fiscal Q2 2014): 26 published measures, 83 facts as tagged in accession 0001354488-13-006773.

This filing

Form: 10-Q (quarterly report)
Filed: 2013-12-10
Fiscal period: fiscal Q2 2014
Accession: 0001354488-13-006773 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All Islet Sciences, Inc filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2013-10-31	3,480,582	USD
At 2013-04-30	3,642,889	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2013-10-31	4,747,945	USD
At 2013-04-30	3,011,084	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2013-10-31	-1,267,363	USD
At 2013-04-30	631,805	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2013-08-01 to 2013-10-31	-715,203	USD	92
2013-05-01 to 2013-10-31	-2,010,057	USD	184
2010-05-04 to 2013-10-31	-19,452,360	USD	1277
2012-08-01 to 2012-10-31	-2,597,873	USD	92
2012-05-01 to 2012-10-31	-7,348,105	USD	184

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2013-05-01 to 2013-10-31	-183,438	USD	184
2010-05-04 to 2013-10-31	-6,649,280	USD	1277
2012-05-01 to 2012-10-31	-2,788,334	USD	184

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2013-05-01 to 2013-10-31	179,919	USD	184
2010-05-04 to 2013-10-31	6,649,350	USD	1277
2012-05-01 to 2012-10-31	1,891,182	USD	184

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Unit	Days
2013-05-01 to 2013-10-31	USD	184
2010-05-04 to 2013-10-31	USD	1277
2012-05-01 to 2012-10-31	USD	184

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2013-10-31	-19,452,360	USD
At 2013-04-30	-17,442,303	USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Unit	Days
2013-08-01 to 2013-10-31	USD	92
2013-05-01 to 2013-10-31	USD	184
2010-05-04 to 2013-10-31	USD	1277
2012-08-01 to 2012-10-31	USD	92
2012-05-01 to 2012-10-31	USD	184

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2013-05-01 to 2013-10-31	14,289	USD	184
2010-05-04 to 2013-10-31	6,177,701	USD	1277
2012-05-01 to 2012-10-31	835,072	USD	184

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2013-08-01 to 2013-10-31	-712,316	USD	92
2013-05-01 to 2013-10-31	-2,004,938	USD	184
2010-05-04 to 2013-10-31	-18,520,786	USD	1277
2012-08-01 to 2012-10-31	-2,594,358	USD	92
2012-05-01 to 2012-10-31	-7,342,626	USD	184

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2013-10-31	2,475	USD
At 2013-04-30	55,994	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2013-08-01 to 2013-10-31	2,887	USD	92
2013-05-01 to 2013-10-31	5,118	USD	184
2010-05-04 to 2013-10-31	15,864	USD	1277
2012-08-01 to 2012-10-31	3,515	USD	92
2012-05-01 to 2012-10-31	5,479	USD	184

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2013-10-31	4,200,945	USD
At 2013-04-30	2,464,084	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2013-10-31	3,512,472	USD
At 2013-04-30	2,233,314	USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

Period	Value	Unit	Days
At 2013-10-31	2,111,107	USD
At 2013-04-30	2,111,107	USD

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2013-08-01 to 2013-10-31	0	USD	92
2013-05-01 to 2013-10-31	766,000	USD	184
2010-05-04 to 2013-10-31	6,914,910	USD	1277
2012-08-01 to 2012-10-31	1,058,363	USD	92
2012-05-01 to 2012-10-31	2,023,295	USD	184

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2013-10-31	56,948,450	shares
At 2013-04-30	56,715,117	shares

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

Period	Value	Unit	Days
At 2013-10-31	1,367,000	USD
At 2013-04-30	1,475,788	USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

Period	Value	Unit	Days
At 2013-10-31	3,478,107	USD
At 2013-04-30	3,586,895	USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

Period	Value	Unit	Days
2013-08-01 to 2013-10-31	-715,203	USD	92
2013-05-01 to 2013-10-31	-2,010,057	USD	184
2010-05-04 to 2013-10-31	-19,452,360	USD	1277
2012-08-01 to 2012-10-31	-2,597,873	USD	92
2012-05-01 to 2012-10-31	-7,348,105	USD	184

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2013-08-01 to 2013-10-31	618,730	USD	92
2013-05-01 to 2013-10-31	1,145,353	USD	184
2010-05-04 to 2013-10-31	11,512,290	USD	1277
2012-08-01 to 2012-10-31	1,535,995	USD	92
2012-05-01 to 2012-10-31	5,319,331	USD	184

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

Period	Value	Unit	Days
2013-05-01 to 2013-10-31	15,202	USD	184
2010-05-04 to 2013-10-31	106,414	USD	1277
2012-05-01 to 2012-10-31	15,202	USD	184

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2013-08-01 to 2013-10-31	-2,887	USD	92
2013-05-01 to 2013-10-31	-5,118	USD	184
2010-05-04 to 2013-10-31	-931,574	USD	1277
2012-08-01 to 2012-10-31	-3,515	USD	92
2012-05-01 to 2012-10-31	-5,479	USD	184

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

Period	Value	Unit	Days
2013-05-01 to 2013-10-31	0	USD	184
2010-05-04 to 2013-10-31	4,597,416	USD	1277
2012-05-01 to 2012-10-31	1,891,182	USD	184

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

Period	Value	Unit	Days
2013-05-01 to 2013-10-31	1,279,158	USD	184
2010-05-04 to 2013-10-31	3,432,919	USD	1277
2012-05-01 to 2012-10-31	395,458	USD	184

Inspect the source

Entity: Islet Sciences, Inc / CIK 0001425919
Captured: 2026-09-23 02:53 UTC
SEC response SHA-256: 772b1f44d9d37bd48844eaa983a8e5f18f2baaa7338282e3b988fe1e34289e0a

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001425919.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))